{"entity":{"type":"insider","cik":"0001253323","url":"/insider/0001253323","json_url":"/insider/0001253323.json","name":"PERSEUSPUR LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":198,"n_filings":19,"first":"2004-01-05","last":"2010-03-10","span_basis":"filed_date"},"name_variants":[{"name":"PERSEUSPUR LLC","source":"filing","n_filings":19,"first_seen":"2004-01-05","last_seen":"2010-03-10"}],"transactions":[{"id":7658239,"accession":"0000950142-10-000407","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950142-10-000407","line_url":"/filing/0000950142-10-000407#line-3","is_derivative":false,"issuer_cik":"0000927752","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0000927752","owner_cik":null,"owner_name":"PERSEUSPUR LLC; PEARL FRANK H","owner_display_name":"PERSEUSPUR LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3925.0,"shares_display":"3,925","price_per_share":16.04,"price_display":"16.04","price_state":"stated","total_value":62957.0,"total_display":"62,957.00","total_whole":"62,957","shares_owned_after":2828962.0,"shares_owned_after_display":"2,828,962","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-03-10","filed_date":"2010-03-10","scope":"insider"},{"id":7658237,"accession":"0000950142-10-000407","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950142-10-000407","line_url":"/filing/0000950142-10-000407#line-2","is_derivative":false,"issuer_cik":"0000927752","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0000927752","owner_cik":null,"owner_name":"PERSEUSPUR LLC; PEARL FRANK H","owner_display_name":"PERSEUSPUR LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.21,"price_display":"15.21","price_state":"stated","total_value":76050.0,"total_display":"76,050.00","total_whole":"76,050","shares_owned_after":2832887.0,"shares_owned_after_display":"2,832,887","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-03-09","filed_date":"2010-03-10","scope":"insider"},{"id":7658234,"accession":"0000950142-10-000407","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950142-10-000407","line_url":"/filing/0000950142-10-000407#line-1","is_derivative":false,"issuer_cik":"0000927752","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0000927752","owner_cik":null,"owner_name":"PERSEUSPUR LLC; PEARL FRANK H","owner_display_name":"PERSEUSPUR LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":14.41,"price_display":"14.41","price_state":"stated","total_value":72050.0,"total_display":"72,050.00","total_whole":"72,050","shares_owned_after":2837887.0,"shares_owned_after_display":"2,837,887","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-03-08","filed_date":"2010-03-10","scope":"insider"},{"id":7641990,"accession":"0000950142-10-000387","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000950142-10-000387","line_url":"/filing/0000950142-10-000387","is_derivative":false,"issuer_cik":"0000927752","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0000927752","owner_cik":null,"owner_name":"PERSEUSPUR LLC; PEARL FRANK H","owner_display_name":"PERSEUSPUR LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25585.0,"shares_display":"25,585","price_per_share":13.95,"price_display":"13.95","price_state":"stated","total_value":356910.75,"total_display":"356,910.75","total_whole":"356,911","shares_owned_after":2842887.0,"shares_owned_after_display":"2,842,887","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-03-05","filed_date":"2010-03-08","scope":"insider","n_lines":3},{"id":7641985,"accession":"0000950142-10-000387","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950142-10-000387","line_url":"/filing/0000950142-10-000387","is_derivative":false,"issuer_cik":"0000927752","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0000927752","owner_cik":null,"owner_name":"PERSEUSPUR LLC; PEARL FRANK H","owner_display_name":"PERSEUSPUR LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14305.0,"shares_display":"14,305","price_per_share":14.23852569031807,"price_display":"14.24","price_state":"stated","total_value":203682.11,"total_display":"203,682.11","total_whole":"203,682","shares_owned_after":2868472.0,"shares_owned_after_display":"2,868,472","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-03-04","filed_date":"2010-03-08","scope":"insider","n_lines":4},{"id":7124429,"accession":"0000950142-07-002393","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950142-07-002393","line_url":"/filing/0000950142-07-002393#line-5","is_derivative":false,"issuer_cik":"0000927752","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0000927752","owner_cik":null,"owner_name":"PERSEUS BIOTECH FUND PARTNERS LLC; PEARL FRANK H; PERSEUSPUR LLC","owner_display_name":"PERSEUS BIOTECH FUND PARTNERS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":175000.0,"shares_display":"175,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":2100000.0,"total_display":"2,100,000.00","total_whole":"2,100,000","shares_owned_after":4076170.0,"shares_owned_after_display":"4,076,170","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-11","filed_date":"2007-10-12","scope":"insider"},{"id":4004799,"accession":"0000950142-06-002315","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950142-06-002315","line_url":"/filing/0000950142-06-002315#line-1","is_derivative":false,"issuer_cik":"0000900203","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0000900203","owner_cik":null,"owner_name":"PERSEUS SOROS BIOPHARMACEUTICAL FUND LP; SFM PARTICIPATION LP; PEARL FRANK H; SFM AH LLC; SOROS FUND MANAGEMENT LLC; SOROS GEORGE; PERSEUSPUR LLC; PERSEUS SOROS PARTNERS LLC; PERSEUS BIOTECH FUND PARTNERS LLC","owner_display_name":"PERSEUS SOROS BIOPHARMACEUTICAL FUND LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500000.0,"shares_display":"1,500,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":24000000.0,"total_display":"24,000,000.00","total_whole":"24,000,000","shares_owned_after":2377403.0,"shares_owned_after_display":"2,377,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-12-05","filed_date":"2006-12-07","scope":"insider"},{"id":1310636,"accession":"0000950142-05-003218","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950142-05-003218","line_url":"/filing/0000950142-05-003218#line-1","is_derivative":false,"issuer_cik":"0000900203","issuer_name":"Adams Respiratory Therapeutics, Inc.","issuer_ticker":"ARXT","issuer_name_source":null,"issuer_url":"/issuer/0000900203","owner_cik":null,"owner_name":"PERSEUS SOROS PARTNERS LLC; PEARL FRANK H; SFM AH LLC; PERSEUS SOROS BIOPHARMACEUTICAL FUND LP; PERSEUSPUR LLC; PERSEUS BIOTECH FUND PARTNERS LLC; SFM PARTICIPATION LP; SOROS FUND MANAGEMENT LLC; SOROS GEORGE","owner_display_name":"PERSEUS SOROS PARTNERS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1715458.0,"shares_display":"1,715,458","price_per_share":43.75,"price_display":"43.75","price_state":"stated","total_value":75051287.5,"total_display":"75,051,287.50","total_whole":"75,051,288","shares_owned_after":3372918.0,"shares_owned_after_display":"3,372,918","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-12-14","filed_date":"2005-12-15","scope":"insider"},{"id":1369931,"accession":"0000950142-05-002163","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950142-05-002163","line_url":"/filing/0000950142-05-002163#line-2","is_derivative":false,"issuer_cik":"0000900203","issuer_name":"Adams Respiratory Therapeutics, Inc.","issuer_ticker":"ARXT","issuer_name_source":null,"issuer_url":"/issuer/0000900203","owner_cik":null,"owner_name":"SFM AH LLC; SOROS FUND MANAGEMENT LLC; PERSEUSPUR LLC; PERSEUS SOROS BIOPHARMACEUTICAL FUND LP; PERSEUS SOROS PARTNERS LLC; SFM PARTICIPATION LP; PEARL FRANK H; SOROS GEORGE; PERSEUS BIOTECH FUND PARTNERS LLC","owner_display_name":"SFM AH LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1609000.0,"shares_display":"1,609,000","price_per_share":15.81,"price_display":"15.81","price_state":"stated","total_value":25438290.0,"total_display":"25,438,290.00","total_whole":"25,438,290","shares_owned_after":5088376.0,"shares_owned_after_display":"5,088,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-26","filed_date":"2005-07-28","scope":"insider"},{"id":1460473,"accession":"0000950142-05-001941","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950142-05-001941","line_url":"/filing/0000950142-05-001941#line-1","is_derivative":false,"issuer_cik":"0000900203","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0000900203","owner_cik":null,"owner_name":"SOROS GEORGE; PERSEUS BIOTECH FUND PARTNERS LLC; SFM PARTICIPATION LP; PERSEUSPUR LLC; SFM AH LLC; SOROS FUND MANAGEMENT LLC; PEARL FRANK H; PERSEUS SOROS BIOPHARMACEUTICAL FUND LP; PERSEUS SOROS PARTNERS LLC","owner_display_name":"SOROS GEORGE","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":612089.0,"shares_display":"612,089","price_per_share":4.9,"price_display":"4.90","price_state":"stated","total_value":2999236.1,"total_display":"2,999,236.10","total_whole":"2,999,236","shares_owned_after":3877403.0,"shares_owned_after_display":"3,877,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-06-30","filed_date":"2005-07-05","scope":"insider"},{"id":1484613,"accession":"0000950142-05-000473","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950142-05-000473","line_url":"/filing/0000950142-05-000473#line-1","is_derivative":false,"issuer_cik":"0000900203","issuer_name":"BARRIER THERAPEUTICS INC","issuer_ticker":"BTRX","issuer_name_source":null,"issuer_url":"/issuer/0000900203","owner_cik":null,"owner_name":"PERSEUS SOROS BIOPHARMACEUTICAL FUND LP; SFM PARTICIPATION LP; PEARL FRANK H; SFM AH LLC; SOROS FUND MANAGEMENT LLC; SOROS GEORGE; PERSEUSPUR LLC; PERSEUS SOROS PARTNERS LLC; PERSEUS BIOTECH FUND PARTNERS LLC","owner_display_name":"PERSEUS SOROS BIOPHARMACEUTICAL FUND LP","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock, par value $.0001 per share (\"Common Stock\")","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":430004.0,"shares_display":"430,004","price_per_share":19.5,"price_display":"19.50","price_state":"stated","total_value":8385078.0,"total_display":"8,385,078.00","total_whole":"8,385,078","shares_owned_after":2324734.0,"shares_owned_after_display":"2,324,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-02-15","filed_date":"2005-02-17","scope":"insider"},{"id":253740,"accession":"0000950142-04-004519","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0000950142-04-004519","line_url":"/filing/0000950142-04-004519","is_derivative":false,"issuer_cik":"0000927752","issuer_name":"BIOENVISION INC","issuer_ticker":"BIVN","issuer_name_source":null,"issuer_url":"/issuer/0000927752","owner_cik":null,"owner_name":"PERSEUSPUR LLC; PEARL FRANK H","owner_display_name":"PERSEUSPUR LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value (\"Common Stock\")","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7102.0,"shares_display":"7,102","price_per_share":8.349738101943114,"price_display":"8.35","price_state":"stated","total_value":59299.84,"total_display":"59,299.84","total_whole":"59,300","shares_owned_after":403784.0,"shares_owned_after_display":"403,784","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-12-22","filed_date":"2004-12-23","scope":"insider","n_lines":30},{"id":234598,"accession":"0000950142-04-004521","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0000950142-04-004521","line_url":"/filing/0000950142-04-004521#line-28","is_derivative":false,"issuer_cik":"0000927752","issuer_name":"BIOENVISION INC","issuer_ticker":"BIVN","issuer_name_source":null,"issuer_url":"/issuer/0000927752","owner_cik":null,"owner_name":"PEARL FRANK H; PERSEUSPUR LLC","owner_display_name":"PEARL FRANK H","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value (\"Common Stock\")","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31.0,"shares_display":"31","price_per_share":8.52,"price_display":"8.52","price_state":"stated","total_value":264.12,"total_display":"264.12","total_whole":"264","shares_owned_after":396758.0,"shares_owned_after_display":"396,758","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-12-22","filed_date":"2004-12-23","scope":"insider"},{"id":234597,"accession":"0000950142-04-004521","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0000950142-04-004521","line_url":"/filing/0000950142-04-004521#line-27","is_derivative":false,"issuer_cik":"0000927752","issuer_name":"BIOENVISION INC","issuer_ticker":"BIVN","issuer_name_source":null,"issuer_url":"/issuer/0000927752","owner_cik":null,"owner_name":"PEARL FRANK H; PERSEUSPUR LLC","owner_display_name":"PEARL FRANK H","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7021.0,"shares_display":"7,021","price_per_share":8.6,"price_display":"8.60","price_state":"stated","total_value":60380.6,"total_display":"60,380.60","total_whole":"60,381","shares_owned_after":379809.0,"shares_owned_after_display":"379,809","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-12-22","filed_date":"2004-12-23","scope":"insider"},{"id":234596,"accession":"0000950142-04-004521","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0000950142-04-004521","line_url":"/filing/0000950142-04-004521#line-26","is_derivative":false,"issuer_cik":"0000927752","issuer_name":"BIOENVISION INC","issuer_ticker":"BIVN","issuer_name_source":null,"issuer_url":"/issuer/0000927752","owner_cik":null,"owner_name":"PEARL FRANK H; PERSEUSPUR LLC","owner_display_name":"PEARL FRANK H","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6181.0,"shares_display":"6,181","price_per_share":8.6,"price_display":"8.60","price_state":"stated","total_value":53156.6,"total_display":"53,156.60","total_whole":"53,157","shares_owned_after":386830.0,"shares_owned_after_display":"386,830","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-12-22","filed_date":"2004-12-23","scope":"insider"},{"id":234595,"accession":"0000950142-04-004521","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0000950142-04-004521","line_url":"/filing/0000950142-04-004521#line-25","is_derivative":false,"issuer_cik":"0000927752","issuer_name":"BIOENVISION INC","issuer_ticker":"BIVN","issuer_name_source":null,"issuer_url":"/issuer/0000927752","owner_cik":null,"owner_name":"PEARL FRANK H; PERSEUSPUR LLC","owner_display_name":"PEARL FRANK H","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1187.0,"shares_display":"1,187","price_per_share":8.7,"price_display":"8.70","price_state":"stated","total_value":10326.9,"total_display":"10,326.90","total_whole":"10,327","shares_owned_after":375044.0,"shares_owned_after_display":"375,044","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-12-22","filed_date":"2004-12-23","scope":"insider"}],"collapsed":true,"next_cursor":"2004-12-22|234595","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001401923","name":"MAP Pharmaceuticals, Inc.","url":"/issuer/0001401923","role":"Ten percent owner","n_filings":3,"first_seen":"2007-10-12","last_seen":"2010-03-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001182129","name":"AUXILIUM PHARMACEUTICALS INC","url":"/issuer/0001182129","role":"Ten percent owner","n_filings":3,"first_seen":"2004-07-30","last_seen":"2006-12-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001319439","name":"Adams Respiratory Therapeutics, Inc.","url":"/issuer/0001319439","role":"Ten percent owner","n_filings":2,"first_seen":"2005-07-28","last_seen":"2005-12-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001173657","name":"BARRIER THERAPEUTICS INC","url":"/issuer/0001173657","role":"Other","n_filings":1,"first_seen":"2005-02-17","last_seen":"2005-02-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001028205","name":"BIOENVISION INC","url":"/issuer/0001028205","role":"Ten percent owner, Other","n_filings":7,"first_seen":"2004-05-17","last_seen":"2004-12-23"},{"type":"issuer","type_label":"ISSUER","cik":"0000947397","name":"EVERGREEN SOLAR INC","url":"/issuer/0000947397","role":"Ten percent owner","n_filings":1,"first_seen":"2004-11-08","last_seen":"2004-11-08"},{"type":"issuer","type_label":"ISSUER","cik":"0000932352","name":"VALENTIS INC","url":"/issuer/0000932352","role":"Ten percent owner","n_filings":2,"first_seen":"2004-01-05","last_seen":"2004-02-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001253323","retrieved_at":"2026-08-25T09:57:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}